By Henry M. Rinder, MD, FASCP, and Alexa J. Siddon, MD, FASCP
Diagnostic hematopathology is evolving through molecular testing to increasingly accurate disease classification. Furthermore, the essential emphasis on a team-based approach to patient care relies on efficient and clear communication between the pathologist, hematologist/oncologist, and the molecular diagnostics laboratory. Some of the hurdles to this collaboration are: [a] choosing the appropriate molecular studies; and [b] integrating these results with histologic and clinical findings.
The ASCP 2018 Annual Meeting session, Hematopathology Molecular Diagnostics: Effectively Integrating Results for Clinical Care, on Oct. 4, will utilize a combined interactive/didactic format that will encompass high yield topics, including: molecular technologies, incorporation of molecular results to refine diagnoses, and communicating results with the entire clinical care team. This session is aimed at laboratory professionals, pathologists, pathology residents, and other doctoral level experts.
The faculty leading the discussion have a spectrum of expertise, including molecular diagnostics, hematopathology, and clinical hematology/oncology. The presentation will focus on choosing appropriate molecular evaluations, understanding the optimal methodologies to utilize when multiple are available, and interpreting molecular results in the individual context. Interactive, case-based studies will facilitate audience participation.
To learn about the ASCP 2018 Annual Meeting’s more than 250 hours of cutting edge education, click here.
Henry M. Rinder, MD, FASCP, John Greg Howe, PhD, and Alexa J. Siddon, MD, FASCP, will present the ASCP 2018 Annual Meeting session titled, “Hematopathology Molecular Diagnostics: Effectively Integrating Results for Clinical Care,” on Thursday, Oct. 4 from 3:00 to 4:30 p.m.